{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:42:40Z","timestamp":1787161360608,"version":"build-2736575974"},"reference-count":111,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA233452"],"award-info":[{"award-number":["P01CA233452"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tem.2024.02.017","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:47:39Z","timestamp":1711360059000},"page":"708-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Unveiling the cancer risk nexus of the steatotic liver"],"prefix":"10.1016","volume":"35","author":[{"given":"Jieun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-6085","authenticated-orcid":false,"given":"Ekihiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2024.02.017_bb0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Diaz","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity \u2013 a longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004836-200304000-00015","article-title":"Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study","volume":"36","author":"Sorensen","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.tem.2024.02.017_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003066","article-title":"Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus","volume":"11","author":"Chen","year":"2023","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.tem.2024.02.017_bb0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cgh.2021.01.005","article-title":"Risk of cancer in biopsy-proven alcohol-related liver disease: a population-based cohort study of 3410 persons","volume":"20","author":"Hagstrom","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0040","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.02.017_bb0045","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.15195","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study","volume":"42","author":"Bjorkstrom","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2024.02.017_bb0050","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2024.02.017_bb0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2024.02.017_bb0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.184","article-title":"Perspectives on youth-onset nonalcoholic fatty liver disease","volume":"3","author":"Castillo-Leon","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.tem.2024.02.017_bb0070","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/hep.29068","article-title":"Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic","volume":"65","author":"Doycheva","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.35511","article-title":"New-onset age of nonalcoholic fatty liver disease and cancer risk","volume":"6","author":"Liu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2024.02.017_bb0080","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.02.017_bb0085","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/hep.31845","article-title":"Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study","volume":"74","author":"Simon","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.06.004","article-title":"Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis","volume":"87","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2024.02.017_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.tem.2024.02.017_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jceh.2022.11.006","article-title":"Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD \u2013 an umbrella overview of systematic review of meta-analysis","volume":"13","author":"Xiao","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10552-018-1095-z","article-title":"Non-alcoholic fatty liver disease and colorectal cancer survival","volume":"30","author":"Wu","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.tem.2024.02.017_bb0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2011.237974","article-title":"High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.02.017_bb0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1440-1746.2009.06117.x","article-title":"Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps","volume":"25","author":"Hwang","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2796.2011.02377.x","article-title":"Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia","volume":"270","author":"Stadlmayr","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tem.2024.02.017_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103996","article-title":"Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer","volume":"79","author":"Truong","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2024.02.017_bb0130","article-title":"Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease","volume":"12","author":"Park","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2024.02.017_bb0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12032-007-0034-8","article-title":"A case-control study of non-alcoholic fatty liver disease in breast cancer","volume":"24","author":"Bilici","year":"2007","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tem.2024.02.017_bb0140","first-page":"242","article-title":"Relationship between non-alcoholic fatty liver disease and breast cancer","volume":"19","author":"Nseir","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.tem.2024.02.017_bb0145","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1002\/cam4.5614","article-title":"Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea","volume":"12","author":"Tran","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.tem.2024.02.017_bb0150","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.29995","article-title":"Cancer incidence among alcoholic liver disease patients in Finland: a retrospective registry study during years 1996-2013","volume":"138","author":"Sahlman","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tem.2024.02.017_bb0155","first-page":"257","article-title":"Alcohol use and the risk of colorectal liver metastasis: a systematic mapping review","volume":"12","author":"Sapkota","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.tem.2024.02.017_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/hepr.13980","article-title":"Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: a Mendelian randomization study","volume":"54","author":"Xie","year":"2024","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.tem.2024.02.017_bb0165","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/bjs.9057","article-title":"Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases","volume":"100","author":"Hamady","year":"2013","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.tem.2024.02.017_bb0170","article-title":"The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tem.2024.02.017_bb0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.hpb.2015.12.002","article-title":"The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma","volume":"18","author":"Ramos","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.tem.2024.02.017_bb0180","first-page":"963","article-title":"Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study","volume":"20","author":"Ocak Duran","year":"2015","journal-title":"J. BUON"},{"key":"10.1016\/j.tem.2024.02.017_bb0185","article-title":"Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery","volume":"98","author":"Lee","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tem.2024.02.017_bb0190","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6612","article-title":"Fatty liver is a risk factor for liver metastasis in Chinese patients with non-small cell lung cancer","volume":"7","author":"Wu","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.tem.2024.02.017_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fonc.2020.00251","article-title":"Effect of non-alcoholic fatty liver disease on the risk of synchronous liver metastasis: analysis of 451 consecutive patients of newly diagnosed colorectal cancer","volume":"10","author":"Lv","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tem.2024.02.017_bb0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/ERC-14-0036","article-title":"Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence","volume":"21","author":"Choi","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2024.02.017_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-017-4411-5","article-title":"Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study","volume":"166","author":"Wu","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tem.2024.02.017_bb0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/j.gastro.2018.11.001","article-title":"Genomic medicine and implications for hepatocellular carcinoma prevention and therapy","volume":"156","author":"Dhanasekaran","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.02.017_bb0215","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4161\/cc.20259","article-title":"The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease","volume":"11","author":"Daugherity","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tem.2024.02.017_bb0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-021-03974-6","article-title":"Convergent somatic mutations in metabolism genes in chronic liver disease","volume":"598","author":"Ng","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0235","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","article-title":"Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation","volume":"17","author":"He","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tem.2024.02.017_bb0245","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-019-11274-x","article-title":"ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy","volume":"10","author":"Tian","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.02.017_bb0250","article-title":"Regulation and targeting of SREBP-1 in hepatocellular carcinoma","author":"Su","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.tem.2024.02.017_bb0255","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.1007\/s11033-021-07094-2","article-title":"Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma","volume":"49","author":"Raeisi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tem.2024.02.017_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.tem.2024.02.017_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","article-title":"Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition","volume":"20","author":"Umemura","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2024.02.017_bb0270","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","article-title":"p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells","volume":"29","author":"Umemura","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0275","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/liv.15682","article-title":"miR-21-5p promotes NASH-related hepatocarcinogenesis","volume":"43","author":"Rodrigues","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2024.02.017_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012370","article-title":"The implications of noncoding RNAs in the evolution and progression of nonalcoholic fatty liver disease (NAFLD)-related HCC","volume":"23","author":"Rusu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.02.017_bb0285","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.tem.2024.02.017_bb0290","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0295","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/gutjnl-2022-327924","article-title":"MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression","volume":"72","author":"Fu","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.02.017_bb0300","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136215","article-title":"Hepatic lipids promote liver metastasis","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2024.02.017_bb0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-mediated metastasis: communication from a distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0310","first-page":"1117","article-title":"Role of extracellular vesicles in liver diseases","volume":"13","author":"Tamasi","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.tem.2024.02.017_bb0315","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","article-title":"IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis","volume":"159","author":"Dasgupta","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.02.017_bb0320","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Wang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2024.02.017_bb0325","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tem.2024.02.017_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113369","article-title":"Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling","volume":"42","author":"Dudgeon","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2024.02.017_bb0335","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0340","article-title":"Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.02.017_bb0345","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06114-4","article-title":"Tumour extracellular vesicles and particles induce liver metabolic dysfunction","volume":"618","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jleuko\/qiad081","article-title":"Lipid metabolism in the immune niche of tumor-prone liver microenvironment","volume":"115","author":"Chen","year":"2024","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.tem.2024.02.017_bb0355","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0360","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0365","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A Causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0375","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0380","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0385","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.02.017_bb0390","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0395","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tem.2024.02.017_bb0400","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/HEP.0000000000000591","article-title":"Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"79","author":"Li","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0405","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0410","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0415","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1158\/2159-8290.CD-20-1628","article-title":"IL27 signaling serves as an immunologic checkpoint for innate cytotoxic cells to promote hepatocellular carcinoma","volume":"12","author":"Aghayev","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tem.2024.02.017_bb0420","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/hep.30693","article-title":"NOD-like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in NAFLD","volume":"70","author":"Ohashi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.02.017_bb0425","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1158\/1078-0432.CCR-18-2123","article-title":"VEGFR1+ metastasis-associated macrophages contribute to metastatic angiogenesis and influence colorectal cancer patient outcome","volume":"25","author":"Freire Valls","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2024.02.017_bb0430","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7314\/APJCP.2013.14.2.1003","article-title":"Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer","volume":"14","author":"Cui","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.tem.2024.02.017_bb0435","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191847","article-title":"Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis","volume":"217","author":"Donadon","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2024.02.017_bb0440","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2015.08.013","article-title":"The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity","volume":"43","author":"Dupaul-Chicoine","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.tem.2024.02.017_bb0445","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","article-title":"Targeting YAP-dependent MDSC infiltration impairs tumor progression","volume":"6","author":"Wang","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tem.2024.02.017_bb0450","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1002\/cncr.24495","article-title":"Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma","volume":"115","author":"Xu","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.tem.2024.02.017_bb0455","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/261365","article-title":"Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma","volume":"2014","author":"Han","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.tem.2024.02.017_bb0460","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cas.12587","article-title":"TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma","volume":"106","author":"Xiao","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tem.2024.02.017_bb0465","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2024.02.017_bb0470","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2023.02.043","article-title":"A therapeutically targetable TAZ\u2013TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23","volume":"164","author":"Saito","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.02.017_bb0475","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1186\/s12885-015-1987-1","article-title":"Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma","volume":"15","author":"Sun","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tem.2024.02.017_bb0480","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1053\/j.gastro.2017.12.013","article-title":"Knockdown of anillin actin binding protein blocks cytokinesis in hepatocytes and reduces liver tumor development in mice without affecting regeneration","volume":"154","author":"Zhang","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.02.017_bb0485","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.gastro.2020.01.026","article-title":"Mice with increased numbers of polyploid hepatocytes maintain regenerative capacity but develop fewer hepatocellular carcinomas following chronic liver injury","volume":"158","author":"Lin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.02.017_bb0490","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2021.11.031","article-title":"TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis","volume":"76","author":"Wang","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2024.02.017_bb0495","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41388-018-0585-5","article-title":"Indian Hedgehog links obesity to development of hepatocellular carcinoma","volume":"38","author":"Chong","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.tem.2024.02.017_bb0500","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0505","doi-asserted-by":"crossref","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","article-title":"The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain","volume":"109","author":"Lamar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tem.2024.02.017_bb0510","doi-asserted-by":"crossref","first-page":"G380","DOI":"10.1152\/ajpgi.00185.2020","article-title":"Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis","volume":"320","author":"Li","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tem.2024.02.017_bb0515","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1101\/gad.294348.116","article-title":"Single tumor-initiating cells evade immune clearance by recruiting type II macrophages","volume":"31","author":"Guo","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.tem.2024.02.017_bb0520","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.aaw9886","article-title":"Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice","volume":"366","author":"Moya","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tem.2024.02.017_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41418-022-01040-w","article-title":"A self-amplifying USP14\u2013TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma","volume":"30","author":"Zhao","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tem.2024.02.017_bb0530","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","article-title":"Hepatocytes direct the formation of a pro-metastatic niche in the liver","volume":"567","author":"Lee","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.02.017_bb0535","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.ymthe.2023.07.012","article-title":"Alcohol reshapes a liver premetastatic niche for cancer by extra- and intrahepatic crosstalk-mediated immune evasion","volume":"31","author":"Qiu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tem.2024.02.017_bb0540","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-017-9838-x","article-title":"Enhanced colorectal cancer metastases in the alcohol-injured liver","volume":"34","author":"Mohr","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.tem.2024.02.017_bb0545","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10555-015-9551-7","article-title":"Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring","volume":"34","author":"McGuire","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.tem.2024.02.017_bb0550","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tem.2024.02.017_bb0555","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.gastro.2023.02.047","article-title":"Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer","volume":"165","author":"Kucukkose","year":"2023","journal-title":"Gastroenterology"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T19:01:56Z","timestamp":1731610916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276024000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1043276024000602"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2024.02.017","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the cancer risk nexus of the steatotic liver","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2024.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}